ibudilast has been researched along with Acute Confusional Senile Dementia in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist." | 5.91 | Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023) |
"Ibudilast is a multi-target drug, as it is a phosphodiesterase inhibitor and toll-like receptor 4 (TLR4) antagonist." | 1.91 | Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation. ( Chaudry, O; Figueiredo-Pereira, ME; Liu, Q; Oliveros, G; Qiu, Y; Rockwell, P; Serrano, PA; Wallace, CH; Xie, L, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Oliveros, G | 1 |
Wallace, CH | 1 |
Chaudry, O | 1 |
Liu, Q | 1 |
Qiu, Y | 1 |
Xie, L | 1 |
Rockwell, P | 1 |
Figueiredo-Pereira, ME | 1 |
Serrano, PA | 1 |
1 other study available for ibudilast and Acute Confusional Senile Dementia
Article | Year |
---|---|
Repurposing ibudilast to mitigate Alzheimer's disease by targeting inflammation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Disease Models, Animal; Drug Repositioning; Femal | 2023 |